Loading...

Humana Inc.

HUMNYSE
HealthcareMedical - Healthcare Plans
$228.75
$-24.11(-9.53%)

Humana Inc. (HUM) Stock Overview

Explore Humana Inc.’s financial performance, market position, analyst ratings, and future outlook.

Revenue Growth
10.70%
10.70%
Profit Growth
$14.20
51.51%
EPS Growth
$14.20
50.17%
Operating Margin
2.78%
36.16%
ROE
10.006%
51.51%
Dividend Yield
0.00%
2.73%

Analyst Recommendations

Strong Buy
0
Buy
3
Hold
5
Sell
1
Strong Sell
0

Price Targets

Low$247.00
Average$320.62
High$419.00

Company Profile

Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, and home solutions services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2021, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

CEO

Mr. James A. Rechtin M.B.A.

Employees

65,680

Headquarters

Humana Building, Louisville, KY

Founded

1981

Frequently Asked Questions

Meyka LogoMeyka

Meyka is the best Alternative Data platform powered by AI providing research insights for investors

Connect With Us

Legal Disclaimer

The information provided by Meyka AI PTY LTD is for informational and research purposes only and does not constitute financial, investment, or trading advice. Meyka is a research platform, not a financial advisory service. Investing in financial markets involves risks, and past performance does not guarantee future results. Users should conduct their own due diligence, consult with professional financial advisors, and assess their risk tolerance before making investment decisions. Meyka and its operators are not liable for any financial losses incurred from the use of information on this platform. The data provided is derived from publicly available sources and is believed to be reliable but may not always be accurate or up to date. Users should independently verify information and not rely solely on Meyka for financial decisions. By using Meyka, you acknowledge that it does not provide financial advice or recommendations and agree to seek guidance from a qualified financial professional before making any investment decisions.

© 2025 Meyka AI PTY LTD. All rights reserved.